ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

Includes Sept. Business & Regulatory Report.

September 26, 2003

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988

“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens

April 9, 1976

CPSC Relies On NCI Findings For New Policy

July 21, 1978